Personal tools
You are here: Home Resources for Health Professionals Research Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene

Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene

Cell Metabolism - 6 January 2010 (Vol. 11, Issue 1, pp. 11-22) -Kristina Kedbacker, Kivanc Birsoy, Robert W. Wysocki, Esra Asilmaz, Rexford S. Ahima, I. Sadaf Farooqi, Jeffrey M. Friedman

Research study that shows that Leptin has been shown to improve hyperglycemia and insulin resistance in a number of clinical settings in animals and humans.

We would like to point out the fact that this research is still in the early stages with regards to human subjects and "further studies will reveal whether IGFBP2 shows similar antidiabetic effects in clinical settings."

Read article online

Download PDF

Document Actions
Education Opportunity


Professional Education Summit
Emerging Trends in Diabetes Care

Saturday, October 17, 2015

EvergreenHealth Medical Center
Kirkland, WA
9:00 am - 4:00 pm

The ADA's first annual CME event in Washington State is designed for primary care physicians, pharmacists, dietitians, nurses, certified diabetes educators, and other healthcare professionals with an interest in diabetes. The Summit is sponsored by Premera Blue Cross and EvergreenHealth.

Register and Learn More:
Online registration only. Space is limited. Go to: 

Have General Questions? 
Contact Brenda Wright at or (206) 282-4616 ext. 7223.


November is National Diabetes Awareness Month!

Share how healthy eating can help manage Diabetes by participating in...


Are you at risk for Type 2 Diabetes?

Diabetes Risk Test